Brookstone Capital Management Innoviva, Inc. Transaction History

Brookstone Capital Management

  • $6.01 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 13, 2022
BUY
$11.61 - $15.22 $15,452 - $20,257
1,331 Added 10.03%
14,597 $189,000
Q2 2022

Jul 11, 2022
BUY
$14.32 - $19.88 $22,081 - $30,654
1,542 Added 13.15%
13,266 $192,000
Q1 2022

Apr 12, 2022
BUY
$15.39 - $20.25 $5,032 - $6,621
327 Added 2.87%
11,724 $225,000
Q4 2021

Jan 11, 2022
BUY
$15.91 - $18.72 $181,326 - $213,351
11,397 New
11,397 $199,000

Others Institutions Holding INVA

# of Institutions
228
Shares Held
79.1M
Call Options Held
37.6K
Put Options Held
300
View Full List

About Innoviva, Inc.

INVA Quotes by TradingView
  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.33B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Brookstone Capital Management Portfolio

Follow Brookstone Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brookstone Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Brookstone Capital Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email